Protein based COVID-19 vaccine

Description

In this Product Explainer, Infectious Disease Physician and Clinical Microbiologist A/Prof Paul Griffin explains the recombinant protein nanoparticle COVID-19 vaccine with a proprietary adjuvant, including the mechanism of action, efficacy, and tolerability; and provides an update on boosters, indications, and access
(8 mins).

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
Prof Jacob George

Prof Jacob George

Fatty Liver, CV Risk, and Post-Menopause

Prof Sebastian King

Prof Sebastian King

Paediatric Constipation & Related Issues

Hayley Ryan

Hayley Ryan

Management of Skin Tear in General Practice

Dr Katherine Spira

Dr Katherine Spira

Migraine vs Chronic Daily Headache

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Prof Paul Griffin

expert

Prof Paul Griffin

Infectious Diseases Physician and Clinical Microbiologist; Director of Infectious Diseases, Mater Hospital; Lecturer, University of Queensland

Date published: 12 July 2023